Ledger.Open graph →
SEC Form D · filed June 23, 2021

BioIntervene, Inc

Offering
$5.6M
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRISBANE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ed Hurwitz · Cambridge, MADirectorGary J. Patou · San Diego, CADirectorSimon J. Tate · Brisbane, CADirectorGary J. Bennett · San Diego, CADirectorDavid J. Bredt · Brisbane, CADirectorDaniela J. Salvemini · San Diego, CADirectorEd Hurwitz · South San Francisco, CADirectorSimon J. Tate · Brisbane, CADirectorGary J. Bennett · San Diego, CADirectorDavid J. Bredt · Brisbane, CADirectorDaniela J. Salvemini · San Diego, CADirectorGary J. Patou · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗